Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CNS Pharmaceuticals, Inc. (CNSP) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 8-K Quarterly results
08/15/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "AMENDED AND RESTATED BYLAWS OF CNS PHARMACEUTICALS, INC."
08/14/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/14/2023 8-K Quarterly results
Docs: "CNS Pharmaceuticals Reports Second Quarter 2023 Financial Results and"
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/01/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
05/15/2023 8-K Quarterly results
Docs: "CNS Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides"
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/08/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Bettina M. Cockroft, M.D., M.B.A., Pharmaceutical and Biotech Industry Veteran, Joins CNS Pharmaceuticals Board of Directors"
05/01/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
03/31/2023 10-K Annual Report for the period ended December 31, 2022
02/14/2023 SC 13G ARMISTICE CAPITAL, LLC reports a 10% stake in CNS Pharmaceuticals, Inc.
01/03/2023 8-K Appointed a new director
Docs: "CNS Pharmaceuticals Appoints Faith L. Charles, JD as Chair of the Board of Directors"
12/14/2022 8-K Quarterly results
12/02/2022 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
12/01/2022 8-K Quarterly results
12/01/2022 EFFECT Form EFFECT - Notice of Effectiveness:
11/28/2022 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Amendment to the Amended and Restated Articles of Incorporation of CNS Pharmaceuticals, Inc., filed with the Secretary of State of the State of Nevada",
"CNS Pharmaceuticals Announces Reverse Stock Split"
11/28/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
11/15/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
11/10/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/24/2022 8-K Quarterly results
10/21/2022 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
08/26/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
08/19/2022 8-K Quarterly results
08/16/2022 8-K Quarterly results
08/15/2022 8-K Quarterly results
08/12/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
07/28/2022 8-K Quarterly results
07/07/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
06/24/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
05/16/2022 8-K Quarterly results
05/13/2022 10-Q Quarterly Report for the period ended March 31, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy